Design, synthesis and evaluation of novel diaryl urea derivatives as potential antitumor agents. 2014

Chenshu Lu, and Ke Tang, and Yan Li, and Peng Li, and Ziyun Lin, and Dali Yin, and Xiaoguang Chen, and Haihong Huang
Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100050, China.

A novel series of diaryl ureas containing different linker groups were designed and synthesized. Their in vitro antitumor activity against MX-1, A375, HepG2, Ketr3 and HT-29 was evaluated using the standard MTT assay. Compounds having a rigid linker group such as vinyl, ethynyl and phenyl showed significant inhibitory activity against a variety of cancer cell lines. Specifically, compound 23 with a phenyl linker group demonstrated broad-spectrum antitumor activity with IC50 values of 5.17-6.46 μM against five tested tumor cell lines. Compound 23 is more potent than reference drug sorafenib (8.27-15.2 μM), representing a promising lead for further optimization.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014508 Urea A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. Basodexan,Carbamide,Carmol
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Chenshu Lu, and Ke Tang, and Yan Li, and Peng Li, and Ziyun Lin, and Dali Yin, and Xiaoguang Chen, and Haihong Huang
January 2016, European journal of medicinal chemistry,
Chenshu Lu, and Ke Tang, and Yan Li, and Peng Li, and Ziyun Lin, and Dali Yin, and Xiaoguang Chen, and Haihong Huang
November 2011, Archiv der Pharmazie,
Chenshu Lu, and Ke Tang, and Yan Li, and Peng Li, and Ziyun Lin, and Dali Yin, and Xiaoguang Chen, and Haihong Huang
October 2014, European journal of medicinal chemistry,
Chenshu Lu, and Ke Tang, and Yan Li, and Peng Li, and Ziyun Lin, and Dali Yin, and Xiaoguang Chen, and Haihong Huang
June 2016, European journal of medicinal chemistry,
Chenshu Lu, and Ke Tang, and Yan Li, and Peng Li, and Ziyun Lin, and Dali Yin, and Xiaoguang Chen, and Haihong Huang
March 2013, Molecules (Basel, Switzerland),
Chenshu Lu, and Ke Tang, and Yan Li, and Peng Li, and Ziyun Lin, and Dali Yin, and Xiaoguang Chen, and Haihong Huang
May 2024, Bioorganic chemistry,
Chenshu Lu, and Ke Tang, and Yan Li, and Peng Li, and Ziyun Lin, and Dali Yin, and Xiaoguang Chen, and Haihong Huang
January 2019, Frontiers in chemistry,
Chenshu Lu, and Ke Tang, and Yan Li, and Peng Li, and Ziyun Lin, and Dali Yin, and Xiaoguang Chen, and Haihong Huang
May 2019, Archiv der Pharmazie,
Chenshu Lu, and Ke Tang, and Yan Li, and Peng Li, and Ziyun Lin, and Dali Yin, and Xiaoguang Chen, and Haihong Huang
November 2016, Molecules (Basel, Switzerland),
Chenshu Lu, and Ke Tang, and Yan Li, and Peng Li, and Ziyun Lin, and Dali Yin, and Xiaoguang Chen, and Haihong Huang
January 2021, European journal of medicinal chemistry,
Copied contents to your clipboard!